Kathryn Cunningham, PsyD

Recent Publications

Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial.
(2021)
Front Psychiatry 12(): 666945
Johns SE, Keyser-Marcus L, Abbate A, Boone E, Van Tassell B, Cunningham KA, Anastasio NC, Poklis JL, Ramey T, Moeller FG

Profiles of juveniles with sex offense charges referred for competence evaluations.
(2021 Apr 25)
J Forensic Sci
Cunningham KA, Edyburn KL, Lexcen F

Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in Adolescence.
(2021 May 21)
Neuroscience 463(): 272-287
Schlagal CR, Dunn TJ, Xu P, Felsing DE, Merritt CR, Manja S, Fox RG, Buffington SA, Saade G, Dineley KT, Yu Y, Cunningham KA, Wu P

Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.
(2021 Jun 1)
Behav Pharmacol 32(4): 335-344
Davis-Reyes BD, Smith AE, Xu J, Cunningham KA, Zhou J, Anastasio NC

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
(2021 Jan)
Pharmacol Rev 73(1): 310-520
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D

Show complete publication list »
Edit Profile